MRC1 and pachyonychia congenita: Their findings showed that PC in these families exceeded expectations from the general population and therefore “...Individuals with MMR gene mutations and a family history of pancreatic cancer are appropriate to include in studies to further define the risk for premalignant and malignant pancreatic neoplasms and potential benefits and limitations of surveillance.”